Alan Lamont

Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial

Mahesh Parmar, Jonathan A. Ledermann, Nicoletta Colombo et al. · The Lancet · 2003 · 1.2K citations

Medicine, Gynecology, Oncology +17

Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trial

Gordon Rustin, Maria EL van der Burg, Clare Griffin et al. · The Lancet · 2010 · 594 citations · Full text

Medicine, Gynecology, Oncology +15

Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of Marimastat After Response to First-Line Chemotherapy in Patients With Small-Cell Lung Cancer: A Trial of the National Cancer Institute of Canada-Clinical Trials Group and the European Organization for Research and Treatment of Cancer

Frances A. Shepherd, Giuseppe Giaccone, Lesley Seymour et al. · Journal of Clinical Oncology · 2002 · 258 citations

Medicine, Oncology, Pharmacotherapy +17

Five-Day Oral Etoposide2 Treatment for Advanced Small-Cell Lung Cancer: Randomized Comparison With Intravenous Chemotherapy

R L Souhami, SG Spiro, R.M. Rudd et al. · JNCI Journal of the National Cancer Institute · 1997 · 203 citations · Full text

Medicine, Oncology, Pharmacology +13

MHC interaction and T cell recognition of carbohydrates and glycopeptides

Glenn Ishioka, Alan Lamont, David Thomson et al. · The Journal of Immunology · 1992 · 169 citations · Full text

Life Sciences, Biochemistry, Immunology +17